<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/css" href="skins/rss_style.css" ?>
<rss version="2.0" >
 <channel>
   <title>FDA news</title>
   <link>http://www.drugspedia.net/news4/news2.php</link>
   <language>en-us</language>
   <description></description>
<!-- <docs>This is an RSS 2.0 file intended to be viewed in a newsreader or syndicated to another site. For more information on RSS check : http://www.feedburner.com/fb/a/aboutrss</docs> -->
   <generator>CuteNews</generator>
<item>
<title><![CDATA[Sanofi's Taxotere gets U.S. approval for use in head and neck cancer]]></title>
<link>http://www.drugspedia.net/news4/news2.php?subaction=showfull&amp;id=1191427635&amp;archive=</link>
<description><![CDATA[SNY 42.50, -0.03, -0.1%) , the world's third largest drugmaker, Monday said the U.S. Food and Drug Administration (FDA) has approved a new application for its anti-cancer drug Taxotere.<br />The drug has been approved to treat locally advanced head and neck cancer prior to chemoradiotherapy and surgery, Sanofi-Aventis said.]]></description>
<guid isPermaLink="false">1191427635</guid>
<pubDate>Wed,  3 Oct 2007 20:07:15 +0400</pubDate>
</item><item>
<title><![CDATA[Standard Medicare Premium Will Rise 3.1% Next Year]]></title>
<link>http://www.drugspedia.net/news4/news2.php?subaction=showfull&amp;id=1191427506&amp;archive=</link>
<description><![CDATA[WASHINGTON, Oct. 1 — The Bush administration announced Monday that the standard Medicare premium would rise to $96.40 a month next year, an increase of $2.90 a month. The 3.1 percent increase is the smallest since 1999-2000, when the premium was at the same level, $45.50, for two years in a row.]]></description>
<guid isPermaLink="false">1191427506</guid>
<pubDate>Wed,  3 Oct 2007 20:05:06 +0400</pubDate>
</item><item>
<title><![CDATA[US FDA Considering 'Behind-The-Counter' Drug Status]]></title>
<link>http://www.drugspedia.net/news4/news2.php?subaction=showfull&amp;id=1191427430&amp;archive=</link>
<description><![CDATA[WASHINGTON -(Dow Jones)- The U.S. Food and Drug Administration said Wednesday it is considering the possibility of establishing a "behind-the-counter" system that could allow more prescription drugs to be sold without customers actually having a prescription for them.]]></description>
<guid isPermaLink="false">1191427430</guid>
<pubDate>Wed,  3 Oct 2007 20:03:50 +0400</pubDate>
</item><item>
<title><![CDATA[FDA halts testing of Idenix drug for hepatitis]]></title>
<link>http://www.drugspedia.net/news4/news2.php?subaction=showfull&amp;id=1184526081&amp;archive=</link>
<description><![CDATA[Idenix Pharmaceuticals Inc., a Cambridge-based drug company, said yesterday that federal regulators suspended testing of its hepatitis C drug, resulting in a 38 percent drop in the company's stock.<br /><br />]]></description>
<guid isPermaLink="false">1184526081</guid>
<pubDate>Sun, 15 Jul 2007 23:01:21 +0400</pubDate>
</item><!-- News Powered by CuteNews: http://cutephp.com/ --></channel></rss>
